GD2 CAR-T CELL THERAPY CLINICAL TRIAL SITE ADMINISTRATION AND CELL DISTRIBUTION LOGISTICS
$1,247,433N01FY2020CANIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
Support to manage cellular product distribution logistics for an autologous CAR T-cell study in pediatric neuroblastoma and osteosarcoma.
View original record on NIH RePORTER →